Oritavancin precursor(A82846B) fermentation technology

TypeName: Business Offer
Category:
Country: United States
Summary: Oritavancin precursor(A82846B) fermentation technology
Description: LY264826 (A82846B) is a naturally-occurring glycopeptide antibiotic. The glycopeptide antibiotic A82846B is the precursor of the semi-synthetic antibiotic oritavancin.

Oritavancin (INN, also known as LY333328, Orbactiv) is a novel semisynthetic glycopeptide antibiotic for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.
OfferId: 2842
Name:Wendy Wilson
Telphone:
Categories